Press Releases Press Releases Regulators Approve Impella 5.5® with SmartAssist® in Japan and Hong Kong; US FDA Grants Impella BTR® Conditional IDE Approval for First-in-Human Early Feasibility Study 19. Jan 2022 Read More Early Feasibility Study Demonstrates Successful Use of Abiomed’s preCARDIA Technology 19. Jan 2022 Read More Two Large Studies Demonstrate Complete Revascularization with Impella® Heart Pumps Improves Ejection Fraction and Long-Term Patient Outcomes 05. Nov 2021 Read More Impella® Advances to Higher Level of Recommendation in Newest ESC Guidelines 04. Nov 2021 Read More TCT 2021 to Highlight Improved Patient Outcomes with Impella’s Small, Smart and Connected Technology 02. Nov 2021 Read More FDA Grants Breakthrough Device Designation to Impella ECP, the World’s Smallest Heart Pump 19. Aug 2021 Read More FDA Grants Highest Level of Approval to the Next Generation of Impella RP to Treat Right Heart Failure 30. Jun 2021 Read More Abiomed Acquires preCARDIA, a Breakthrough Medical Device Company, to Improve Outcomes for Heart Failure Patients 01. Jun 2021 Read More First Patient Enrolled in PROTECT IV Randomized Controlled Trial of Impella® 16. Apr 2021 Read More 1 2 NPS-2558
